GLOBEFLEX CAPITAL L P - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLOBEFLEX CAPITAL L P ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$643,000
+21.1%
25,563
+0.3%
0.14%
-2.8%
Q3 2020$531,000
-12.4%
25,4990.0%0.14%
-8.4%
Q2 2020$606,000
+60.3%
25,499
+21.3%
0.15%
+32.8%
Q1 2020$378,000
-24.2%
21,0270.0%0.12%
+24.7%
Q4 2019$499,000
-16.8%
21,027
-3.7%
0.09%
-29.0%
Q3 2019$600,000
-31.7%
21,839
-17.7%
0.13%
-28.4%
Q2 2019$878,000
-5.7%
26,539
-0.1%
0.18%
-7.1%
Q1 2019$931,000
+3.0%
26,561
-2.4%
0.20%
-8.4%
Q4 2018$904,000
-48.6%
27,219
-22.1%
0.22%
-37.9%
Q3 2018$1,760,000
-16.8%
34,961
-1.1%
0.35%
-19.9%
Q2 2018$2,116,000
+21.1%
35,361
-7.3%
0.43%
+16.8%
Q1 2018$1,748,000
+130.0%
38,161
+100.2%
0.37%
+74.5%
Q4 2017$760,000
-0.3%
19,0610.0%0.21%
-2.3%
Q3 2017$762,000
+32.3%
19,061
+42.7%
0.22%
+52.8%
Q2 2017$576,000
+37.8%
13,3610.0%0.14%
+43.4%
Q1 2017$418,000
+24.0%
13,3610.0%0.10%
+17.9%
Q4 2016$337,000
+45.3%
13,361
-22.7%
0.08%
+35.5%
Q4 2015$232,000
-4.1%
17,2780.0%0.06%
+19.2%
Q3 2015$242,000
-86.0%
17,278
-83.0%
0.05%
-83.5%
Q2 2015$1,725,000
+172400.0%
101,578
+158615.6%
0.32%
Q1 2015$1,0000.0%64
-31.9%
0.00%
Q4 2014$1,0000.0%94
-14.5%
0.00%
Q3 2014$1,0001100.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders